Shares of Glenmark Life Sciences (GLS) slipped below its issue price of Rs 720 per share on the BSE in intra-day trade on Monday as the stock declined 5 per cent to Rs 713.85. With today’s decline, the stock of the pharmaceutical company has slipped 11 per cent from its listing day high of Rs 799.95.
On Friday, August 6, 2021, GLS had made a quiet debut on the bourses as the shares listed at Rs 751.10, a 4 per cent premium against issue price on the BSE.
GLS, a developer and manufacturer of active pharmaceutical ingredients (APIs), is a wholly-owned subsidiary